Company intelligence / Profile preview

Solaria Clinic

Tokyo, Tokyo-to, Japan

Ownership: Private
Development stage: Other

Overview

Solaria Clinic Tokyo offers advanced regenerative medicine therapies based on protracted research into deciduous tooth pulp stem cells, adipose-derived stem cell culture supernatant, and novel cancer immunotherapies targeting NKT cells, with clinical use in male health and cancer.

Therapeutic areas: Men's HealthOncologyDermatologyOther
Modalities: Stem cell therapyCell therapyCancer immunotherapyAdipose-derived stem cell therapyNKT cell therapy
Industry: Non-Academic Healthcare

Partnerships

Panajee Co., Ltd. (cell processing facilities)Riken Immunotherapy Medicine Co., Ltd. (cancer immunotherapy technology)Jinsei Society Edogawa Hospital group (joint clinical implementation)

Beyond the preview

Go deeper on Solaria Clinic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solaria Clinic.

Explore the full profile